Trademark: 79401859
Word
LNJ
Status
Pending
Status Code
630
Status Date
Thursday, August 8, 2024
Serial Number
79401859
Mark Type
4
Filing Date
Thursday, May 2, 2024

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the treatment of brain disease using technology capable of passing through the blood-brain barrier (BBB) to deliver therapeutic proteins directly to brain tissue, using the DAT (dual action therapy) platform for medical purposes; pharmaceutical preparations for the treatment of Alzheimer's disease (senile dementia); pharmaceutical preparations for the treatment of brain disease for medical purposes; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of neurodegenerative brain diseases for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease.
42 Conducting clinical trials in the field of brain, central nervous system diseases; research and development of vaccines and medicines; development of cell therapy products; drug discovery services; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research laboratory services for predicting disease; medical research laboratory services in the field of the blood-brain barrier (BBB); medical research laboratory services in the field of Alzheimer's disease.

Trademark Events
Aug 8, 2024
Sn Assigned For Sect 66a Appl From Ib
Aug 19, 2024
New Application Office Supplied Data Entered
Aug 19, 2024
Application Filing Receipt Mailed

Trademark Alertz updated from USPTO on 2030-01-24